Organization · Venture Capital
Double Point Ventures
Double Point Ventures is a healthcare-focused venture capital firm based in Boston, Massachusetts, investing in early-stage transformative companies. The firm emphasizes high-conviction investments in therapeutics, diagnostics, medical devices, and digital health.
Overview
What Double Point Ventures does
What Double Point Ventures is
Double Point Ventures is a healthcare-focused venture capital firm based in Boston, Massachusetts, investing in early-stage transformative companies. The firm emphasizes high-conviction investments in therapeutics, diagnostics, medical devices, and digital health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find Double Point Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Double Point Ventures as a funder
Investment thesis
Double Point Ventures focuses on early-stage investments in transformative healthcare companies, emphasizing innovations that can fundamentally change patient care.
Focus narrative
The firm invests across various areas in healthcare, including therapeutics (small molecules, biologics, gene and cell therapies, precision medicine), diagnostics and devices (early-revenue and innovative platforms), and digital health and healthcare services (early revenue-stage models). Double Point Ventures emphasizes strategic partnerships and operational guidance to support its portfolio companies.
Value beyond capital
Double Point Ventures provides strategic partnerships, operational guidance, and a long-term commitment to its portfolio companies, enhancing their potential for success in the healthcare market.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
- Sectors
- Healthcare · Biotech · Digital Health · Medical Devices
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
- Recorded notable exits
- Lumos Pharma
Portfolio context
Notable portfolio companies include Synchron, a leading brain-computer interface company; GEMMA Biotherapeutics, focused on gene therapy; Lumos Pharma, which was acquired in a $27.65M tender offer; and DermBiont, specializing in targeted topical dermatological therapeutics with a $35.2M Series B funding.
Common questions
What to know about Double Point Ventures
Upseed classifies Double Point Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.